3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
6
Prostatic Neoplasms
4
Brain Neoplasms
4
Pancreatic Neoplasms
3
Glioblastoma
3
Sarcoma
2
Neoplasms
2
Lung Neoplasms
2
Gliosarcoma
2
Glioma
2
Urothelial Carcinoma of the Bladder
1
Thoracic Neoplasms
1
Stage IA-IIA Breast Cancer
1
Rhabdomyosarcoma
1
Retinoblastoma
1
Resected Pancreatic Adenocarcinoma
1
Recurrence
1
Pinealoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Meningioma
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Gastrointestinal Neoplasms
1
Eye Neoplasms
1
Esophageal Neoplasms
1
Ependymoma
1
Desmoplastic Small Round Cell Tumor
1
Chordoma
1
Chondrosarcoma
1
Interventions
pazopanib
2
Radiotherapy
2
Ifosfamide
2
Doxorubicin
2
romidepsin
1
indolepropanol phosphate
1
Watchful Waiting
1
Surgical Procedures, Operative
1
Sunitinib
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiation
1
Polymerase Chain Reaction
1
Observation
1
Neoadjuvant Therapy
1
HhAntag691
1
Gene Expression Profiling
1
Gemcitabine
1
Drug Therapy
1
Blotting, Western
1
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Chondrosarcoma, Extraskeletal Myxoid
×
Proton Therapy
×
Clear all
No trials found.